The Efficacy of Lenvatinib Plus Everolimus in Patients with Metastatic Renal Cell Carcinoma Exhibiting Primary Resistance to Front-Line Targeted Therapy or Immunotherapy
Lana Hamieh, Rachel Beck, Valerie H. Le, James J. Hsieh
Topics & Concepts
LenvatinibMedicineEverolimusInternal medicineOncologyTargeted therapyRenal cell carcinomaRegimenSunitinibCombination therapyCabozantinibRefractory (planetary science)Tyrosine-kinase inhibitorSorafenibCancerHepatocellular carcinomaAstrobiologyPhysicsRenal cell carcinoma treatmentRenal and related cancersConnective Tissue Growth Factor Research